byiShook Opinion
Dec 20, 2024 - 18:35
Eli Lilly gained FDA approval late Friday for its weight-loss drug, Zepbound, as a treatment for obstructive sleep apnea. The post Eli Lilly's Obesity Drug Wins Approval In Sleep Apnea; Will ResMed Dive? appeared first on Investor's Business Daily.
Eli Lilly gained FDA approval late Friday for its weight-loss drug, Zepbound, as a treatment for obstructive sleep apnea.
The post Eli Lilly's Obesity Drug Wins Approval In Sleep Apnea; Will ResMed Dive? appeared first on Investor's Business Daily.